Search

Your search keyword '"Tolosa, C."' showing total 306 results

Search Constraints

Start Over You searched for: Author "Tolosa, C." Remove constraint Author: "Tolosa, C."
306 results on '"Tolosa, C."'

Search Results

101. Silent pulmonary embolism in patients with proximal deep vein thrombosis in the lower limbs

102. Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis

103. Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry

104. KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor

105. Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis

106. Venous thromboembolism in patients with intracranial haemorrhage

107. Acute venous thromboembolism after non-major orthopaedic surgery or post-traumatic limb immobilisation

109. FRI0418 Outcome of the Autoimmune Congenital Heart Block in 45 Babies from Anti-RO/LA (+) Mothers: Results from the Spanish Registry (Rebacc-Geas-Semi)

110. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism

112. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility

113. [Procalcitonin in the early diagnosis of invasive bacterial infection in febrile infants]

114. The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis.

115. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort

116. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis

117. Giant cell (temporal) arteritis and secondary renal amyloidosis: report of 2 cases

118. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis

119. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with Systemic Sclerosis in a large European cohort

121. No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus

123. [Primary antiphospholipid syndrome: study of 27 patients]

133. Fetal loss treatment in patients with antiphospholipid antibodies.

135. [Tumorous lymphedema of the penis. Report of verrucous elephantiasis. A brief case. Preliminary note]

136. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis

137. Prevention of venous thromboembolism in patients with cancer in Spain

138. Clinical and epidemiological differences between men and women with systemic sclerosis: A study in a Spanish systemic sclerosis cohort and literature review

139. LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition

141. Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE)

142. No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis

144. Natural history of patients developing thrombocytopenia while receiving anticoagulant therapy for venous thromboembolism

145. Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus

146. Serodiscordant patients with systemic sclerosis: When antibody does not correspond to skin involvement

148. Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus

149. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis

Catalog

Books, media, physical & digital resources